Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // October 3rd, 2008 // 7:32 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
Each week, this little item notes various comings and goings, but today we would like to stop to acknowledge a very untimely departure. Kim Cayz, a member of the public relations team at Hoffmann-La Roche, passed away last week of a brain tumor. She was just 39 years old. A smart and classy person, Kim was always helpful and straightforward. We know her colleagues are quite upset and hope that she left many good memories.
Cell Therapeutics named Christina Waters president of CTI Europe;
Noven Pharma hired Pete Amanatides as vp quality assurance & quality control;
Tekmira Pharma added Tammy Mullarky as vp strategic planning & biz development;
Tekmira Pharma added Peter Lutwyche as vp pharma development;
AuthentiDate Holding hired Zachary Madrigal as Western region sales mgr;
Biotec Pharmacon hired Sven Rohmann as vp business development;
Immunogen promoted Dan Junius to ceo and president;
Alnylam hired John Schmidt Jr as chief scientific officer;
Bristol-Myers named Chris Perley as vp & general mgr of its Devens biologics plant;
Ipsos Healthcare hired Paul Snyderman as a senior-level research officer;
US Oncology named Michael Sicuro exec vp and cfo;
Neotropix appointed Anthony Williams as chief medical officer;
Ferring named Paul Korner vp, medical affairs.
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Alnylam Pharmaceuticals, AuthentiDate, Biotec Pharmacon, Bristol Myers Squibb, Cell Therapeutics, Ferring, Immunogen, Ipsos Healthcare, Neotropix, Noven Pharmaceuticals, Roche, Tekmira Pharmaceuticals, US Oncology